Undetermined

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	2

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-002109-70-CZ (EUCTR)	12/08/2019	27/12/2018	A research aimed study to test the efficacy and safety of a new medical product, called E6011, in tr ...	Early phase 2 clinical trial of E6011 in patients with active Crohn’s disease - Not applicable	Active Crohn’s disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's dis ...	Product Code: E6011 INN or Proposed INN: Undetermined Other descriptive name: IGG2 ANTIBODIES	EA Pharma Co., Ltd.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	Czechia;Hungary;Czech Republic;Poland;Russian Federation;Japan
2	EUCTR2018-002109-70-HU (EUCTR)	15/04/2019	20/11/2018	A research aimed study to test the efficacy and safety of a new medical product, called E6011, in tr ...	Early phase 2 clinical trial of E6011 in patients with active Crohn’s disease - Not applicable	Active Crohn’s disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's dis ...	Product Code: E6011 INN or Proposed INN: Undetermined Other descriptive name: IGG2 ANTIBODIES	EA Pharma Co., Ltd.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	Czech Republic;Hungary;Poland;Japan

First Previous1Next Last